Form 4: Medtronic Director Scott C. Donnelly Acquires Shares and Restricted Stock Units

Director Scott C. Donnelly reports acquisition of Medtronic shares and restricted stock units.

Summary

• On April 29, 2024, Scott C. Donnelly, a director of Medtronic plc, acquired 2,165 ordinary shares at a price of $80.86 per share.
• These shares were acquired through an award of restricted stock units that vest on the one-year anniversary of the award date.
• Following the transaction, Donnelly's total beneficial ownership of Medtronic ordinary shares is 19,796, which includes 148 shares acquired through dividend reinvestment since the last report.

Sentiment

Score: 6

Explanation: Neutral sentiment as it reports a standard transaction. The director's purchase is a mildly positive signal, but it's a routine filing.

Positives

• The acquisition of shares by a director can be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The restricted stock units will vest on the one-year anniversary of the award date.

Industry Context

Directors' stock acquisitions are common in publicly traded companies and are often viewed as a sign of management's confidence in the company's prospects. This Form 4 filing is a routine disclosure required by the SEC.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment.

Key Dates